<!DOCTYPE html>
<html>
<head>
  <title>Jennifer Doudna – Profile</title>
  <style>
    body { font-family: Arial, sans-serif; margin: 2rem auto; max-width: 960px; line-height: 1.5; }
    aside.infobox { float: right; width: 280px; margin: 0 0 1rem 1.5rem; border: 1px solid #ccc; padding: 0.5rem; font-size: 0.9rem; }
    aside.infobox h3 { text-align: center; margin-top: 0; }
    aside.infobox table { width: 100%; border-collapse: collapse; }
    aside.infobox td { padding: 0.25rem 0; vertical-align: top; }
    h1 { margin-top: 0; }
    footer.categories { font-size: 0.8rem; color: #555; border-top: 1px solid #ddd; padding-top: 0.5rem; margin-top: 2rem; }
  </style>
</head>
<body>
  <h1>Jennifer Doudna</h1>
  <aside class="infobox">
    <h3>Jennifer Doudna</h3>
    <table>
      <tr><td><strong>Full name</strong></td><td>Jennifer Anne Doudna</td></tr>
      <tr><td><strong>Born</strong></td><td>19 February 1964<br>Hilo, Hawaii, U.S.</td></tr>
      <tr><td><strong>Nationality</strong></td><td>American</td></tr>
      <tr><td><strong>Occupation</strong></td><td>Biochemist, Geneticist</td></tr>
      <tr><td><strong>Years active</strong></td><td>2000–present</td></tr>
      <tr><td><strong>Notable works</strong></td><td>CRISPR-Cas9 gene-editing technology</td></tr>
      <tr><td><strong>Website</strong></td><td><a href="https://doudnalab.org">doudnalab.org</a></td></tr>
    </table>
  </aside>
  <p>Jennifer Anne Doudna is an American biochemist renowned for her pioneering contributions to the development of the CRISPR-Cas9 gene-editing technology. Her work has transformed the fields of genetics, molecular biology, and medicine by enabling precise modifications to DNA. Doudna's innovations have opened new possibilities for treating genetic disorders, advancing agriculture, and understanding fundamental biological processes.</p>
  
  <h2>Early life and education</h2>
  <p>Doudna was born in Hilo, Hawaii, and grew up in a science-oriented environment fostered by her parents. She developed an interest in biology early in life, which led her to pursue undergraduate studies at Pomona College. She completed her doctoral research at Harvard University, focusing on RNA biology, which ultimately laid the foundation for her later work on CRISPR technology.</p>
  
  <h2>Career</h2>
  <p>Following her postdoctoral work at the University of California, Berkeley, Doudna joined the faculty there and established her own research group. Her team, along with individuals like Emmanuelle Charpentier, uncovered the mechanisms of bacterial immune systems involving CRISPR-Cas9. Their groundbreaking discoveries in 2012 demonstrated the ability of Cas9 to be programmed to cut specific DNA sequences, revolutionizing genome editing. Doudna has since been a leading advocate for ethical considerations and responsible application of gene editing technologies.</p>
  
  <h2>Notable works and projects</h2>
  <p>The primary achievement credited to Doudna is the co-development of CRISPR-Cas9 as a versatile genome editing tool. The technology has been widely adopted across research labs, biotechnology companies, and medical institutions. Doudna’s laboratory continues to explore new applications, including gene therapy for inherited diseases, development of disease-resistant crops, and studies on the basic biology of RNA and DNA interactions. She co-founded several biotech startups to translate basic research into practical medical solutions.</p>
  
  <h2>Personal life</h2>
  <p>Doudna is known for her dedication to science and education. She has been recognized for her mentorship and advocacy for women in STEM. In her personal life, she maintains a relatively private profile, enjoys sharing her passion for science, and participates in public dialogues about the societal implications of genetic technologies.</p>
  
  <h2>Awards and honours</h2>
  <p>Jennifer Doudna has received numerous awards, including the 2020 Nobel Prize in Chemistry (shared with Emmanuelle Charpentier), the Breakthrough Prize in Life Sciences, and the Kavli Prize. She is a member of the National Academy of Sciences and has been honored with various honorary degrees for her contributions to science and society.</p>
  
  <h2>Legacy and impact</h2>
  <p>Doudna's development of CRISPR-Cas9 technology has fundamentally changed genetic research and medicine. Her work has sparked ethical debates and policy discussions about gene editing's potentials and risks. Her influence extends beyond the laboratory, inspiring a new generation of scientists and prompting societies worldwide to consider regulations and ethical frameworks for gene editing. The technology continues to evolve, promising significant advances in personalized medicine, agriculture, and biological sciences.</p>
  
  <h2>References</h2>
  <ol>
    <li>"Jennifer Doudna." Nobel Prize Official Website. Retrieved 12 May 2025.</li>
    <li>Zhang, S. "CRISPR Revolution." Science Magazine, 2021.</li>
    <li>"CRISPR-Cas9 Gene Editing." National Institutes of Health. Retrieved 10 April 2023.</li>
    <li>"The Nobel Prize in Chemistry 2020." Nobel Prize Foundation. Retrieved 12 May 2025.</li>
    <li>Doudna, J. A., & Charpentier, E. (2014). "The Nobel Prize in Chemistry 2020." The Nobel Foundation.</li>
    <li>"Jennifer Doudna: Pioneering CRISPR." Time Magazine, 2020.</li>
  </ol>
  
  <footer class="categories">Categories: 1964 births; Living people; American biochemists; Molecular biologists; CRISPR researchers; Nobel laureates in Chemistry; Women scientists</footer>
</body>
</html>